DXCM vs LFST · P/E 63, rev $2.50B vs P/E 146, rev $838.8M
DexCom Inc (DXCM) versus Lifestance Health Group Inc (LFST) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Lifestance Health Group Inc (LFST) is a medical care facilities company listed on NASDAQ.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported LFST revenue for 2026-06-30 was $838.8M. Net income was $37.9M. LFST currently screens at market cap $3.35B and trailing P/E 146.2.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. LFST currently screens at market cap $3.35B and trailing P/E 146.2.
Not investment advice. Open the DXCM and LFST stock pages for the full models.
Not investment advice.